§ 285e–10a. Alzheimer’s clinical research and training awards
310 words·~1 min read·
/usc/title-42/section-285e-10aA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Director of the Institute is authorized to establish and maintain a program to enhance and promote the translation of new scientific knowledge into clinical practice related to the diagnosis, care and treatment of individuals with Alzheimer’s disease. In order to foster the application of the most current developments in the etiology, pathogenesis, diagnosis, prevention and treatment of Alzheimer’s disease, amounts made available under this section shall be directed to the support of promising clinicians through awards for research, study, and practice at centers of excellence in Alzheimer’s disease research and treatment. Research shall be carried out under awards made under subsection
(b)in environments of demonstrated excellence in neuroscience, neurobiology, geriatric medicine, and psychiatry and shall foster innovation and integration of such disciplines or other environments determined suitable by the Director of the Institute. ( July 1, 1944, ch. 373 , title IV, § 445I, as added Pub. L. 106–505, title VIII, § 801(2) , Nov. 13, 2000 , 114 Stat. 2349 ; amended Pub. L. 109–482, title I, § 103(b)(25) , Jan. 15, 2007 , 120 Stat. 3688 .)
Connections8 cite this
4 references not yet in our index
- Pub. L. 106-505
- 114 Stat. 2349
- Pub. L. 109-482
- 120 Stat. 3688
Citation graph
cites case law
§ 285e–10a
Alzheimer’s clinical research and training awards
Fed. Reg.×8
Pub. L.Pub. L. 106-505
Stat.114 Stat. 2349
Pub. L.Pub. L. 109-482
Stat.120 Stat. 3688
Cites 4Cited by 8 across 1 source